Quantitative proteomics analysis of cortical samples of 10 Alzheimer’s disease (AD) brains versus 10 normally aged brains was performed by following the accurate mass and time tag (AMT) approach with the high resolution LTQ Orbitrap mass spectrometer. More than 1400 proteins were identified and quantitated. A conservative approach of selecting only the consensus results of four normalization methods was suggested and used. A total of 197 proteins were shown to be significantly differentially abundant (<i>p</i>-values <0.05, corrected for multiplicity of testing) in AD versus control brain samples. Thirty-seven of these proteins were reported as differentially abundant or modified in AD in previous proteomics and transcriptomics publications...
Proteomics involves the identification of unknown proteins following their separation, often using t...
Abstract Proteomic studies of human Alzheimer’s disease brain tissue have potential to identify prot...
Abstract Alzheimer’s disease (AD) is a complex neurodegenerative disorder with impaired protein acti...
Quantitative proteomics analysis of cortical samples of 10 Alzheimer’s disease (AD) brains versus 10...
Abstract Background The complicated cellular and biochemical changes that occur in brain during Alzh...
Abstract Mass spectrometry-based proteomics empowers deep profiling of proteome and protein posttran...
Alzheimer's disease (AD) is a chronic neurodegenerative disease characterized by intracellular forma...
Mass spectrometry (MS)-based proteomics is a powerful tool to explore pathogenic changes of a diseas...
The use of public Alzheimer’s Disease proteomics data to analyze the difference between asymptomatic...
Abstract Although the genetic causes for several rare, familial forms of Alzheimer’s disease (AD) ha...
<div><p>Alzheimer’s disease is a neurodegenerative disorder accounting for more than 50% of cases of...
This project involved proteomics analysis of public data comparing the abundance of significantly ch...
Proteomics involves the identification of unknown proteins following their separation, often using t...
Abstract Proteomic studies of human Alzheimer’s disease brain tissue have potential to identify prot...
Abstract Alzheimer’s disease (AD) is a complex neurodegenerative disorder with impaired protein acti...
Quantitative proteomics analysis of cortical samples of 10 Alzheimer’s disease (AD) brains versus 10...
Abstract Background The complicated cellular and biochemical changes that occur in brain during Alzh...
Abstract Mass spectrometry-based proteomics empowers deep profiling of proteome and protein posttran...
Alzheimer's disease (AD) is a chronic neurodegenerative disease characterized by intracellular forma...
Mass spectrometry (MS)-based proteomics is a powerful tool to explore pathogenic changes of a diseas...
The use of public Alzheimer’s Disease proteomics data to analyze the difference between asymptomatic...
Abstract Although the genetic causes for several rare, familial forms of Alzheimer’s disease (AD) ha...
<div><p>Alzheimer’s disease is a neurodegenerative disorder accounting for more than 50% of cases of...
This project involved proteomics analysis of public data comparing the abundance of significantly ch...
Proteomics involves the identification of unknown proteins following their separation, often using t...
Abstract Proteomic studies of human Alzheimer’s disease brain tissue have potential to identify prot...
Abstract Alzheimer’s disease (AD) is a complex neurodegenerative disorder with impaired protein acti...